Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

• Anat Achiron,
• Mathilda Mandel,
• Sapir Dreyer-Alster,
• Gil Harari,
• David Magalashvili,
• Polina Sonis,
• Mark Dolev,
• Shay Menascu,
• Shlomo Flechter,
• Rina Falb,
• Michael Gurevich

Affiliations

Anat Achiron

Mathilda Mandel

Sapir Dreyer-Alster

Gil Harari

David Magalashvili

Polina Sonis

Mark Dolev

Shay Menascu

Shlomo Flechter

Rina Falb

Michael Gurevich